A Human-Based Integrated Framework forAlzheimer’s Disease Research

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Journal of Alzheimer's Disease

• Publication date

  2015-08-11

• Fields of study

  Biology, Medicine, Computer Science

• Identifiers
  DOI 10.3233/JAD-150281PMID 26401764
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Fatty Acid Profiles in Demented Patients: Identification of Hexacosanoic Acid (C26:0) as a Blood Lipid Biomarker of Dementia

  2015cited by this paper
• The potential of tissue engineering for developing alternatives to animal experiments: a systematic review

  2015cited by this paper
• Insulin resistance predicts brain amyloid deposition in late middle‐aged adults

  2015cited by this paper
• What are the Benefits of Exercise for Alzheimer's Disease? A Systematic Review of the Past 10 Years.

  2015cited by this paper
• Sleep and Alzheimer’s Disease

  2015cited by this paper
• Role of Environmental Contaminants in the Etiology of Alzheimer's Disease: A Review

  2015cited by this paper
• National Institutes of Health funding for behavioral interventions to prevent chronic diseases.

  2015cited by this paper
• Curcumin Binding to Beta Amyloid: A Computational Study

  2015cited by this paper
• Human-on-a-chip design strategies and principles for physiologically based pharmacokinetics/pharmacodynamics modeling.

  2015cited by this paper
• Association between the catechol‐O‐methyltransferase polymorphism Val158Met and Alzheimer's disease in a Japanese population

  2015cited by this paper
• Supportive CSF biomarker evidence to enhance the National Institute on Aging-Alzheimer's Association criteria for diagnosis of Alzheimer's type dementia--a study from Southern India.

  2015cited by this paper
• Relation between Uric Acid and Alzheimer's Disease in Elderly Jordanians

  2015cited by this paper
• Sleep disorders, obesity, and aging: the role of orexin.

  2015cited by this paper
• Environment, epigenetics and neurodegeneration: Focus on nutrition in Alzheimer's disease.

  2015cited by this paper
• Sleep and Alzheimer's disease.

  2015cited by this paper
• 3D reconstruction of neurons in electron microscopy images

  2014cited by this paper
• Registering Cortical Surfaces Based on Whole-Brain Structural Connectivity and Continuous Connectivity Analysis

  2014cited by this paper
• Animal models of Alzheimer disease: historical pitfalls and a path forward.

  2014cited by this paper
• Serum Metabolomic Biomarkers of Dementia

  2014cited by this paper
• Physical activity attenuates age-related biomarker alterations in preclinical AD

  2014cited by this paper
• Variants in PPP3R1 and MAPT are associated with more rapid functional decline in Alzheimer's disease: The Cache County Dementia Progression Study

  2014cited by this paper
• A three-dimensional human neural cell culture model of Alzheimer’s disease

  2014cited by this paper
• Is Cognitive Training an Effective Treatment for Preclinical and Early Alzheimer's Disease?

  2014cited by this paper
• Inhibition of ERK-DLP1 signaling and mitochondrial division alleviates mitochondrial dysfunction in Alzheimer's disease cybrid cell.

  2014cited by this paper
• Chlorpyrifos PBPK/PD model for multiple routes of exposure

  2014cited by this paper
• 'The clocks that time us'—circadian rhythms in neurodegenerative disorders

  2014cited by this paper
• Sleep and Alzheimer disease pathology—a bidirectional relationship

  2014cited by this paper
• Instant neurons: directed somatic cell reprogramming models of central nervous system disorders.

  2014cited by this paper
• The epigenetic dimension of Alzheimer's disease: causal, consequence, or curiosity?

  2014cited by this paper
• Mediterranean Diet and Magnetic Resonance Imaging-Assessed Brain Atrophy in Cognitively Normal Individuals at Risk for Alzheimer's Disease.

  2014cited by this paper
• Computational Design of Apolipoprotein E4 Inhibitors for Alzheimer's Disease Therapy from Traditional Chinese Medicine

  2014cited by this paper
• Serum Uric Acid Levels in Patients with Alzheimer's Disease: A Meta-Analysis

  2014cited by this paper
• Inflammation, defective insulin signaling, and neuronal dysfunction in Alzheimer's disease

  2014cited by this paper
• Applications of linking PBPK and PD models to predict the impact of genotypic variability, formulation differences, differences in target binding capacity and target site drug concentrations on drug responses and variability

  2014cited by this paper
• Population PKPD Modeling of BACE1 Inhibitor-Induced Reduction in Aβ Levels In Vivo and Correlation to In Vitro Potency in Primary Cortical Neurons from Mouse and Guinea Pig

  2014cited by this paper
• Amyloid-β diurnal pattern: possible role of sleep in Alzheimer's disease pathogenesis.

  2014cited by this paper
• Associations between serum cholesterol levels and cerebral amyloidosis.

  2014cited by this paper
• The sleep-wake cycle and Alzheimer's disease: what do we know?

  2014cited by this paper
• Is Alzheimer's disease related to metabolic syndrome? A Wnt signaling conundrum.

  2014cited by this paper
• The Alzheimer structural connectome: changes in cortical network topology with increased amyloid plaque burden.

  2014cited by this paper
• Possible role of orexin in the pathogenesis of Alzheimer disease.

  2014cited by this paper
• Cerebrospinal Fluid Level of YKL-40 Protein in Preclinical and Prodromal Alzheimer's Disease

  2014cited by this paper
• High Manganese, A Risk for Alzheimer's Disease: High Manganese Induces Amyloid-β Related Cognitive Impairment

  2014cited by this paper
• Genetics of Alzheimer's disease.

  2014cited by this paper
• Lost in translation: animal models and clinical trials in cancer treatment.

  2014cited by this paper
• HDL and cholesterol handling in the brain.

  2014cited by this paper
• Impaired glycemia increases disease progression in mild cognitive impairment.

  2014cited by this paper
• The mitochondrial O-linked N-acetylglucosamine transferase (mOGT) in the diabetic patient could be the initial trigger to develop Alzheimer disease.

  2014cited by this paper
• Role of plant-based diets in the prevention and regression of metabolic syndrome and neurodegenerative diseases

  2014cited by this paper
• Considering a new paradigm for Alzheimer's disease research.

  2014cited by this paper
• Clinical indications for analysis of Alzheimer's disease CSF biomarkers.

  2013cited by this paper
• Thrombin, a mediator of cerebrovascular inflammation in AD and hypoxia

  2013cited by this paper
• Mediterranean diet habits in older individuals: associations with cognitive functioning and brain volumes.

  2013cited by this paper
• Alzheimer disease in the United States (2010–2050) estimated using the 2010 census

  2013influential reference
• Integrative genomics identifies APOE ε4 effectors in Alzheimer's disease

  2013cited by this paper
• Food, Nutrigenomics, and Neurodegeneration—Neuroprotection by What You Eat!

  2013cited by this paper
• Remodeling neurodegeneration: somatic cell reprogramming-based models of adult neurological disorders.

  2013cited by this paper
• CREB regulates the expression of neuronal glucose transporter 3: a possible mechanism related to impaired brain glucose uptake in Alzheimer’s disease

  2013cited by this paper
• Patient-derived stem cells: pathways to drug discovery for brain diseases

  2013cited by this paper
• Short-Term Memory in Networks of Dissociated Cortical Neurons

  2013cited by this paper
• 2013 Alzheimer's disease facts and figures

  2013cited by this paper
• Look back in anger - what clinical studies tell us about preclinical work.

  2013cited by this paper
• The National Institutes of Health Microphysiological Systems Program focuses on a critical challenge in the drug discovery pipeline

  2013cited by this paper
• Alzheimer's Disease

  2013cited by this paper
• Socioeconomic status as a risk factor for dementia death: individual participant meta-analysis of 86 508 men and women from the UK

  2013cited by this paper
• LDL Phenotype in Subjects with Mild Cognitive Impairment and Alzheimer’s Disease

  2013cited by this paper
• Modeling Alzheimer's disease with iPSCs reveals stress phenotypes associated with intracellular Aβ and differential drug responsiveness.

  2013cited by this paper
• A Map of Alzheimer's Disease–Signaling Pathways: A Hope for Drug Target Discovery

  2013cited by this paper
• Structural networks in Alzheimer's disease.

  2013cited by this paper
• Proinflammatory cytokines, aging, and age-related diseases.

  2013cited by this paper
• Magnetic resonance spectroscopy in Alzheimer’s disease

  2013cited by this paper
• Genetics of Alzheimer's Disease

  2013cited by this paper
• Why is homocysteine toxic for the nervous and immune systems?

  2013cited by this paper
• The influence of vascular risk factors on cognitive decline in patients with dementia: a systematic review.

  2013cited by this paper
• From Genetics to Dietetics: The Contribution of Epidemiology to Understanding Alzheimer's Disease

  2012cited by this paper
• Induced pluripotent stem cells as tools for disease modelling and drug discovery in Alzheimer’s disease

  2012cited by this paper
• Conversion from mild cognitive impairment to dementia: Influence of folic acid and vitamin B12 use in the vita cohort

  2012cited by this paper
• Stem cell models of Alzheimer's disease and related neurological disorders

  2012cited by this paper
• Hypocretin (orexin) loss in Alzheimer's disease.

  2012cited by this paper
• Lipids and Adipokines as Risk Factors for Alzheimer's Disease

  2012cited by this paper
• Copper excess, zinc deficiency, and cognition loss in Alzheimer's disease

  2012cited by this paper
• Effects of Polyphenols on Brain Ageing and Alzheimer’s Disease: Focus on Mitochondria

  2012cited by this paper
• ‘Human-on-a-chip’ Developments: A Translational Cutting-edge Alternative to Systemic Safety Assessment and Efficiency Evaluation of Substances in Laboratory Animals and Man?

  2012cited by this paper
• The genetics of Alzheimer disease.

  2012cited by this paper
• Potential benefits of adherence to the Mediterranean diet on cognitive health

  2012cited by this paper
• Cognitive activity, education and socioeconomic status as preventive factors for mild cognitive impairment and Alzheimer's disease.

  2012cited by this paper
• Association of Biomarkers for Inflammation, Endothelial Dysfunction and Oxidative Stress with Cognitive Impairment. The Epidemiology of Hearing Loss Study (EHLS).

  2012cited by this paper
• Probing sporadic and familial Alzheimer’s disease using induced pluripotent stem cells

  2012cited by this paper
• Air Pollution, Oxidative Stress, and Alzheimer's Disease

  2012cited by this paper
• Phosphoproteome profiling of substantia nigra and cortex regions of Alzheimer’s disease patients

  2012cited by this paper
• Drug development: Raise standards for preclinical cancer research

  2012cited by this paper
• Microengineered physiological biomimicry: organs-on-chips.

  2012cited by this paper
• Induced pluripotent stem cells: a new tool to confront the challenge of neuropsychiatric disorders.

  2011cited by this paper
• Induced pluripotent stem cells — opportunities for disease modelling and drug discovery

  2011cited by this paper
• Alzheimer's disease.

  2011cited by this paper
• Epigenetic mechanisms in Alzheimer's disease.

  2011cited by this paper
• Alzheimer's disease genetics: current knowledge and future challenges

  2011cited by this paper
• Ultra-High Field 7T MRI: A New Tool for Studying Alzheimer's Disease

  2011cited by this paper
• Tractography: Where Do We Go from Here?

  2011cited by this paper
• Induced pluripotent stem cells in the study of neurological diseases

  2011cited by this paper

• It’s Time to Review the Three Rs, to Make them More Fit for Purpose in the 21st Century

  2024cites this paper
• Recent advances and current challenges of new approach methodologies in developmental and adult neurotoxicity testing

  2024cites this paper
• Human‐based new approach methodologies to accelerate advances in nutrition research

  2024cites this paper
• Impact of micronutrients and nutraceuticals on cognitive function and performance in Alzheimer's disease.

  2024cites this paper
• Sensor‐integrated brain‐on‐a‐chip platforms: Improving the predictive validity in neurodegenerative research

  2023cites this paper
• Poor Translatability of Biomedical Research Using Animals — A Narrative Review

  2023cites this paper
• The future of Parkinson's disease research: A new paradigm of human-specific investigation is necessary… and possible.

  2022cites this paper
• A Tau-Driven Adverse Outcome Pathway Blueprint Toward Memory Loss in Sporadic (Late-Onset) Alzheimer’s Disease with Plausible Molecular Initiating Event Plug-Ins for Environmental Neurotoxicants

  2021cites this paper
• Links between Nutrition, Infectious Diseases, and Microbiota: Emerging Technologies and Opportunities for Human-Focused Research

  2020cites this paper
• Beyond the 3Rs: Expanding the use of human-relevant replacement methods in biomedical research.

  2019cites this paper
• Pathology, Prevention and Therapeutics of Neurodegenerative Disease

  2019cites this paper
• Animal Research for Alzheimer Disease: Failures of Science and Ethics

  2019cites this paper
• Rheumatoid arthritis research in the 21st century: Limitations of traditional models, new technologies, and opportunities for a human biology-based approach.

  2019cites this paper
• Multifarious Therapeutic Avenues for Alzheimer’s Disease

  2018cites this paper
• A randomised double-blind placebo-controlled pilot trial of a combined extract of sage, rosemary and melissa, traditional herbal medicines, on the enhancement of memory in normal healthy subjects, including influence of age.

  2018cites this paper
• Adverse outcome pathways: Application to enhance mechanistic understanding of neurotoxicity

  2017cites this paper
• Towards a 21st-century roadmap for biomedical research and drug discovery: consensus report and recommendations.

  2017cites this paper
• Animal extremists' threats to neurologic research continue: Neuroreality II.

  2016cites this paper
• Advances in Stem Cell Research- A Ray of Hope in Better Diagnosis and Prognosis in Neurodegenerative Diseases

  2016cites this paper
• Animal extremists' threats to neurologic research continue: Neuroreality II

  2016cites this paper
• Meta-Analysis of Transcriptome Data Related to Hippocampus Biopsies and iPSC-Derived Neuronal Cells from Alzheimer’s Disease Patients Reveals an Association with FOXA1 and FOXA2 Gene Regulatory Networks

  2016cites this paper
• Alzheimer disease research in the 21st century: past and current failures, new perspectives and funding priorities

  2016cites this paper
• Role of gut microbiota and nutrients in amyloid formation and pathogenesis of Alzheimer disease.

  2016cites this paper
• Author Response.

  2016cites this paper